Inventor
Ning Zou
Inventor
San Diego, CA, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes20%
C07BGeneral methods of organic chemistry5%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
10,793,529Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators202010,689,372Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto202010,668,033Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto202010,624,972Conjugates for treating diseases202010,214,518Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto201910,138,210Substituted pyridazines as prostacyclin receptor modulators20189,987,252Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto20189,663,500'Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto'20179,328,107'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20169,012,478'Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto'20158,940,891'Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto'2015RE045336'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20158,895,776'Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto'20148,664,258'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20148,148,417'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2020Patents assigned to ARENA PHARM INC (14)· patent assignee history
2012–2015Patents assigned to TRAN THUY-ANH (4)· patent assignee history
2012–2015Patents assigned to ZOU NING (4)· patent assignee history
2012–2014Patents assigned to CHAPMAN DENNIS (2)· patent assignee history
2012–2014Patents assigned to CHOI JUYI (2)· patent assignee history
2012–2020Based in San Diego, CA, US· patent location history
2020Based in West Lafayette, IN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARENA PHARM INC | 14 | 2012–2020 |
| TRAN THUY-ANH | 4 | 2012–2015 |
| ZOU NINGself | 4 | 2012–2015 |
| CHAPMAN DENNIS | 2 | 2012–2014 |
| CHOI JUYI | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 14 | 2012–2020 |
| West Lafayette, IN, US | 1 | 2020 |